Our Impact
Advancing discoveries, knowledge, and innovation to improve human health.
Adopting principles of translational science to improve the translational research process.
2006 – 2024 Highlights
- $ 213 M
- NIH CTSA funding to CUIMC
- $ 15.4 M+
- In funding for 450 pilot awards
- $ 472 M+
- In 237 follow-on grants
- 120
- T-Trainees
- 71
- Irving Scholars
- 86
- K-Scholars
- 171
- Graduates in Master of Science in Patient-Oriented Research
- 371
- Participants in the Columbia Summer Research Institute Training Program
2021 – 2024 Support and Impact
- 70 +
- Irving Institute research services offered
- 1,018
- Consults provided to 823 investigators
- 2,168
- Services, pilot awards, and trainings provided
- 300
- Community Health Workers trained (including 60+ hired to NIH projects)
- 17,546
- Outpatient visits
- 1,877
- Allied research personnel trained
- 78
- Community-based and faith-based organization collaborations
- ~ 30,000
- Health screenings for Upper Manhattan community members
Narratives of Discovery
View interviews with today’s top scientists by Rita Charon, MD, PhD.
A Model for Collaboration
Learn how the Irving Institute develops, demonstrates, and disseminates innovations.
Testimonials
-
Dr. Kousteni leveraged TRx program support to access expertise and resources that advanced the project and enabled additional translational experiments.
-
Dr. Baldwin’s work on frailty and critical illness recovery was supported through Irving Institute funding, training, and research resources, helping advance his NIH K23-funded research.
-
Dr. Bruce’s brain tumor research has been supported by the Irving Institute’s Clinical Research Resource, helping advance innovative drug delivery approaches and complex patient-oriented clinical trials in neuro-oncology.
-
Dr. Chernick advanced her research through a pilot award and KL2 Mentored Career Development Award, enabling early mobile health studies and progression to independent funding in adolescent health.
